Movement Alert|Everpure Rises 7.3% in Regular Trading, FY2028 Revenue Guidance Significantly Exceeds Analyst Expectations

Market Focus
Sep 24

On September 24, Everpure rose 7.3% in regular trading, trading at $119.715/share, with turnover of $104 million.

On the news front, Everpure unveiled a more ambitious long-term growth strategy and issued preliminary FY2028 guidance well above Wall Street expectations. The company projected FY2028 revenue of $7.0 billion to $7.3 billion, representing 39%-45% year-over-year growth, with non-GAAP operating profit of $1.7 billion to $1.9 billion, implying 80%-100% growth. Simultaneously, Everpure reaffirmed its FY2027 revenue guidance of $5.03 billion to $5.07 billion and non-GAAP operating profit of $940 million to $960 million, largely in line with the FactSet consensus of $5.05 billion.

The guidance builds on strong recent momentum. In its FY2027 Q2 report released in August, the company posted adjusted EPS of $0.70, beating estimates by 20.69%, and revenue of $1.186 billion, exceeding expectations by approximately 8%. Piper Sandler subsequently raised its price target to $162 from $133, maintaining an Overweight rating. The stock has also benefited from its formal inclusion in the S&P 500 index on September 21 and the recent announcement of a second hyperscaler design and supply contract.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10